Honghai Tang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Author Correction: A base editor for the long-term restoration of auditory function in mice with recessive profound deafness.

Author Correction: A base editor for the long-term restoration of auditory function in mice with recessive profound deafness.

Journal: Nature biomedical engineering

Published: September 07, 2026

Age outweighs route for AAV-PHP.eB transgene distribution via inner ear delivery.

Age outweighs route for AAV-PHP.eB transgene distribution via inner ear delivery.

Journal: Drug delivery and translational research

Published: March 21, 2026

Schizantherin B alleviates cisplatin-induced ototoxicity and does not interfere cisplatin-based chemotherapy in a breast cancer model.

Schizantherin B alleviates cisplatin-induced ototoxicity and does not interfere cisplatin-based chemotherapy in a breast cancer model.

Journal: Archives of toxicology

Published: October 27, 2025

Erratum: Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primates.

Erratum: Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primates.

Journal: Molecular therapy. Methods & clinical development

Published: September 02, 2025

Hearing restoration by gene replacement therapy for a multisite-expressed gene in a mouse model of human DFNB111 deafness.

Hearing restoration by gene replacement therapy for a multisite-expressed gene in a mouse model of human DFNB111 deafness.

Journal: American journal of human genetics

Published: August 21, 2025

Re-administration of AAV-mediated gene therapy for OTOF-related deafness: a single-arm trial.

Re-administration of AAV-mediated gene therapy for OTOF-related deafness: a single-arm trial.

Journal: Nature medicine

Published: August 12, 2025

Gene Therapy vs Cochlear Implantation in Restoring Hearing Function and Speech Perception for Individuals With Congenital Deafness.

Gene Therapy vs Cochlear Implantation in Restoring Hearing Function and Speech Perception for Individuals With Congenital Deafness.

Journal: JAMA neurology

Published: July 21, 2025

Comparative analysis of RNA versus protein splicing in dual AAV-mediated gene therapy in a mouse model of DFNB9 deafness.

Comparative analysis of RNA versus protein splicing in dual AAV-mediated gene therapy in a mouse model of DFNB9 deafness.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 26, 2025

Leonurine protects against cisplatin-induced ototoxicity through its anti-oxidation and anti-apoptosis properties.

Leonurine protects against cisplatin-induced ototoxicity through its anti-oxidation and anti-apoptosis properties.

Journal: Toxicology letters

Published: January 02, 2025

Audiological characteristics following gene therapy in patients with autosomal recessive deafness 9.

Audiological characteristics following gene therapy in patients with autosomal recessive deafness 9.

Journal: Med (New York, N.Y.)

Published: December 20, 2024

PAM-flexible adenine base editing rescues hearing loss in a humanized MPZL2 mouse model harboring an East Asian founder mutation.

PAM-flexible adenine base editing rescues hearing loss in a humanized MPZL2 mouse model harboring an East Asian founder mutation.

Journal: Nature communications

Published: November 15, 2024

Preliminary evidence for enhanced auditory cortex activation and mental development after gene therapy in children with autosomal recessive deafness 9.

Preliminary evidence for enhanced auditory cortex activation and mental development after gene therapy in children with autosomal recessive deafness 9.

Journal: Nature human behaviour

Published: June 27, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026